Modeling for Health Care and Other Policy Decisions: Uses, Roles and Validity
2001
This is a review article of the role of modeling approaches to guide decision making in health care and other domains. The role of models to support recommendations on the cost-effective use of medical technologies and pharmaceuticals is controversial. At the heart of the controversy is the degree to which experimental or other empirical evidence should be required prior to model use.
The authors argue that the controversy stems in part from a misconception that the role of models is to establish truth rather than to guide clinical and policy decisions. In other domains of public policy that involve human life and health, such as environmental protection and defense strategy, models are generally accepted as decision aids, and many models have been formally incorporated into regulatory processes and governmental decision making.
The authors formulate an analytical framework for evaluating the role of models as aids to decision making. Implications for the implementation of Section 114 of the Food and Drug Administration Modernization Act (FDAMA) are derived from this framework.
Modeling for Health Care and Other Policy Decisions: Uses, Roles and Validity
Source:
Weinstein MC, Toy EL, Sandberg EA, Neumann PJ, Kuntz KM, Hammitt JK et al. Modeling for Health Care and Other Policy Decisions: Uses, Roles, and Validity. Value in Health 2001; 4 (5): 348-361. https://doi.org/10.1046/j.1524-4733.2001.45061.x